GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CLS Holdings USA Inc (XCNQ:CLSH) » Definitions » 3-Year EBITDA Growth Rate

CLS Holdings USA (XCNQ:CLSH) 3-Year EBITDA Growth Rate : 44.40% (As of Feb. 2024)


View and export this data going back to 2019. Start your Free Trial

What is CLS Holdings USA 3-Year EBITDA Growth Rate?

CLS Holdings USA's EBITDA per Share for the three months ended in Feb. 2024 was C$-0.04.

During the past 3 years, the average EBITDA Per Share Growth Rate was 44.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of CLS Holdings USA was 44.40% per year. The lowest was -253.30% per year. And the median was -4.15% per year.


Competitive Comparison of CLS Holdings USA's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, CLS Holdings USA's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CLS Holdings USA's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CLS Holdings USA's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where CLS Holdings USA's 3-Year EBITDA Growth Rate falls into.



CLS Holdings USA 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


CLS Holdings USA  (XCNQ:CLSH) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


CLS Holdings USA 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of CLS Holdings USA's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


CLS Holdings USA (XCNQ:CLSH) Business Description

Traded in Other Exchanges
Address
1800 Industrial Road, Suite 100, Las Vegas, NV, USA, 89102
CLS Holdings USA Inc is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for Cannabis Life Sciences in recognition of the company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services. The company generates the majority of its revenues and corresponding accounts receivable from the sale of cannabis, and cannabis related products.